A $350M Acquisition Could Transform This Struggling Stock
Highlights:
Despite a lacklustre decade of growth, this animal health business is showing signs of a turnaround.
A recent acquisition for $350 million seems like an absolute slam-dunk, poised to significantly boost profits, margins, and scale.
With the company's new CFO having intimate knowledge of the acquired business, the risk of a bad deal seems mitigated.
At under 8x EBITDA, there’s plenty of room for continued upside.